SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-20-113682
Filing Date
2020-10-09
Accepted
2020-10-09 08:14:48
Documents
13
Period of Report
2020-10-09

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2032781d1_6k.htm 6-K 49423
2 GRAPHIC tm2032781d1_6kimg001.jpg GRAPHIC 350747
3 GRAPHIC tm2032781d1_6kimg002.jpg GRAPHIC 596486
4 GRAPHIC tm2032781d1_6kimg003.jpg GRAPHIC 677732
5 GRAPHIC tm2032781d1_6kimg004.jpg GRAPHIC 670923
6 GRAPHIC tm2032781d1_6kimg005.jpg GRAPHIC 631465
7 GRAPHIC tm2032781d1_6kimg006.jpg GRAPHIC 722409
8 GRAPHIC tm2032781d1_6kimg007.jpg GRAPHIC 711445
9 GRAPHIC tm2032781d1_6kimg008.jpg GRAPHIC 681152
10 GRAPHIC tm2032781d1_6kimg009.jpg GRAPHIC 703640
11 GRAPHIC tm2032781d1_6kimg010.jpg GRAPHIC 470734
12 GRAPHIC tm2032781d1_6kimg011.jpg GRAPHIC 518889
13 GRAPHIC tm2032781d1_6kimg012.jpg GRAPHIC 310112
  Complete submission text file 0001104659-20-113682.txt   9750320
Mailing Address 1585 BROADWAY SUITE 2376 NEW YORK NY 10036
Business Address 1585 BROADWAY SUITE 2376 NEW YORK NY 10036 212-969-3335
Grifols SA (Filer) CIK: 0001438569 (see all company filings)

IRS No.: 000000000
Type: 6-K | Act: 34 | File No.: 001-35193 | Film No.: 201232125
SIC: 2834 Pharmaceutical Preparations